Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 9 von 178
Open Access
Arginase and vascular aging
Journal of applied physiology (1985), 2008-11, Vol.105 (5), p.1632-1642
2008
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Arginase and vascular aging
Ist Teil von
  • Journal of applied physiology (1985), 2008-11, Vol.105 (5), p.1632-1642
Ort / Verlag
Bethesda, MD: Am Physiological Soc
Erscheinungsjahr
2008
Quelle
MEDLINE
Beschreibungen/Notizen
  • Departments of 1 Anesthesiology and Critical Care Medicine and 2 Biomedical Engineering; and Johns Hopkins University School of Medicine, Baltimore, Maryland; and 3 Roy and Diana Vagalos Research Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania Submitted 12 May 2008 ; accepted in final form 14 August 2008 ABSTRACT Vascular and associated ventricular stiffness is one of the hallmarks of the aging cardiovascular system. Both an increase in reactive oxygen species production and a decrease in nitric oxide (NO) bioavailability contribute to the endothelial dysfunction that underlies this vascular stiffness, independent of other age-related vascular pathologies such as atherosclerosis. The activation/upregulation of arginase appears to be an important contributor to age-related endothelial dysfunction by a mechanism that involves substrate ( L -arginine) limitation for NO synthase (NOS) 3 and therefore NO synthesis. Not only does this lead to impaired NO production but also it contributes to the enhanced production of reactive oxygen species by NOS. Although arginase abundance is increased in vascular aging models, it appears that posttranslational modification by S -nitrosylation of the enzyme enhances its activity as well. The S -nitrosylation is mediated by the induction of NOS2 in the endothelium. Furthermore, arginase activation contributes to aging-related vascular changes by mechanisms that are not directly related to changes in NO signaling, including polyamine-dependent vascular smooth muscle proliferation and collagen synthesis. Taken together, arginase may represent an as yet elusive target for the modification of age-related vascular and ventricular stiffness contributing to cardiovascular morbidity and mortality. nitric oxide synthase 3; S -nitrosylation; vascular stiffness; L -arginine pools; nitric oxide synthase uncoupling Address for reprint requests and other correspondence: D. E. Berkowitz, Johns Hopkins Hospital, Tower 711, 600 N. Wolfe St., Baltimore, MD 21287 (e-mail: dberkow1{at}jhmi.edu )

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX